The successful candidate will contribute to high-impact research focused on pancreatic beta-cell dysfunction in Type 2 Diabetes.
Base: $127,436 (pro rata); Bonus/Equity: Not specified; Benefits: 17% superannuation
Must-have
Nice-to-have
Not specified